SEARCH

SEARCH BY CITATION

References

  • 1
    British National Formulary. (BNF 63). London: Pharmaceutical Press, 2012.
  • 2
    Lader M. Benzodiazepines revisited – will we ever learn? Addiction 2011; 106: 20862109.
  • 3
    Baenninger A, Costa e Silva JA, Hindmarch A, Moeller HJ, Rickels K. Good Chemistry: The Life and Legacy of Valium Inventor Leo Sternbach. New York: McGraw-Hill, 2004.
  • 4
    Gorenstein C, Bernik MA, Pompeia S. Differential acute psychomotor and cognitive effects of diazepam on long-term benzodiazepine users. Int Clin Psychopharmacol 1994; 9: 145153.
  • 5
    Curran H. Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biol Psychol 1986; 23: 179213.
  • 6
    Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004; 18: 3748.
  • 7
    Verdoux H, Lagnaoui R, Begaud B. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 2005; 35: 307315.
  • 8
    Leung SY. Benzodiazepines, opioids and driving: an overview of the experimental research. Drug Alcohol Rev 2011; 30: 281286.
  • 9
    Skegg DCC, Richards SM, Doll R. Minor tranquillisers and road accidents. BMJ 1979; 1: 917919.
  • 10
    Dassanayake T, Michie P, Carter G, Jones A. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf 2011; 34: 125156.
  • 11
    Orriols L, Philip P, Moore N, Castot A, Gadegbeku B, Delorme B, Mallaret M, Lagarde E. Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clin Pharmacol Ther 2011; 89: 595601.
  • 12
    Maxwell HG, Dubois S, Weaver B, Bédard M. The additive effects of alcohol and benzodiazepines on driving. Can J Public Health 2010; 101: 353357.
  • 13
    Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363369.
  • 14
    Paton C. Benzodiazepines and disinhibition: a review. Psychiatr Bull 2002; 26: 460462.
  • 15
    Authier N, Balayssac D, Sautereau M, Zangarelli A, Courty P, Somogyi AA, Vennat B, Llorca PM. Benzodiazepine dependence: focus on withdrawal syndrome. Ann Pharm Fr 2009; 67: 408413.
  • 16
    Wu CS, Wang SC, Chang IS, Lin KM. The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. Am J Geriatr Psychiatry 2009; 17: 614620.
  • 17
    Bierman EJ, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman AT. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? Int J Geriatr Psychiatry 2007; 22: 11942000.
  • 18
    Dikeos DC, Soldatos CR. The pharmacotherapy of insomnia: efficacy and rebound with hypnotic drugs. Primary Care Companion. J Clin Psychiatry 2002; 4: (Suppl 1): 2732.
  • 19
    Poyares D, Guilleminault C, Ohayon MM, Tufik S. Chronic benzodiazepine usage and withdrawal in insomnia patients. J Psychiatr Res 2004; 38: 327334.
  • 20
    Fontaine R, Beaudry P, Le Morvan P, Beauclair L, Chouinard G. Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. Int Clin Psychopharmacol 1990; 5: 173183.
  • 21
    Lader M. Long-term anxiolytic therapy: the issue of drug withdrawal. J Clin Psychiatry 1987; 48: (Suppl): 1216.
  • 22
    Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. Br J Addict 1987; 82: 655671.
  • 23
    Vikander B, Koechling UM, Borg S, Tönne U, Hiltunen AJ. Benzodiazepine tapering: a prospective study. Nord J Psychiatry 2010; 64: 273282.
  • 24
    Kan CC, Breteler MHM, Zitmann FG. High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatr Scand 1997; 96: 8593.
  • 25
    Russell VJ, Lader M. Guidelines for the Prevention and Treatment of Benzodiazepine Dependence. London: Mental Health Foundation, 1993.
  • 26
    UK Department of Health and the Devolved Administrations. Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Department of Health, 2007.
  • 27
    Kripke DF, Langer RD, Kline LE. Hypnotic association with mortality or cancer; a matched cohort study. BMJ Open 2012; 2: e000850.
  • 28
    Charlson F l, Degenhardt L, McLaren J, Hall W, Lynskey M. A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf 2009; 18: 93103.
  • 29
    Donoghue J, Lader M. Usage of benzodiazepines; a review. Int J Psychiatry Clin Pract 2010; 14: 7887.
  • 30
    Prescription Services Division of the NHS Business Services Authority. Available at http://www.nhsba.nhs.uk/PrescriptionServices.aspx (last accessed 30 August 2012).
  • 31
    Manthey L, Van Veen T, Giltay EJ, Stoop JE, Neven AK, Penninx BW, Zitman FG. Correlates of (inappropriate) benzodiazepine use: the Netherlands Study of Depression and Anxiety (NESDA). Br J Clin Pharmacol 2011; 71: 263272.
  • 32
    Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder; systematic review and meta-analysis. BMJ 2011; 342: d1199.
  • 33
    Lader MH. Hypnotics. How effective are they for insomnia? Psychiatr Times 2009; May: 2325.
  • 34
    Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007; 22: 13351350.
  • 35
    Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331: 11691173.
  • 36
    National Institute for Health and Clinical Excellence. Anxiety. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. Clinical Guideline 113. March 2011. London: National Institute for Health and Clinical Excellence.
  • 37
    National Institute for Health and Clinical Excellence. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. Technology Appraisal 77. April 2004. London: National Institute for Health and Clinical Excellence.
  • 38
    Wade AG, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Curr Med Res Opin 2011; 27: 7898.
  • 39
    Wiegand MH. Antidepressants for the treatment of insomnia; a suitable approach? Drugs 2008; 68: 24112417.
  • 40
    National Center on Addiction and Substance Abuse at Columbia University. You've Got Drugs! Prescription Drug Pushers on the Internet. New York: Columbia University, 2006.
  • 41
    Ashton CH. Benzodiazepines: how they work and how to withdraw. (Revised Edition 2011), University of Newcastle, 2002.
  • 42
    Parr JM, Kavanagh DJ, Cahill L, Mitchell G, Young RM. Effectiveness of current treatment approaches for benzodiazepine discontinuation; a meta-analysis. Addiction 2008; 104: 1324.
  • 43
    Baillargeon L, Landreville P, Verreault R, Beauchemin J-P, Grégoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering; a randomized trial. Can Med Assoc J 2003; 169: 10151020.
  • 44
    Denis C, Fatseas M, Lavie E, Auriacombe M. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev 2006; (3)CD005194.
  • 45
    Hadley SJ, Mandel F, Schweitzer E. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial. J Psychopharmacol 2012; 26: 461470.
  • 46
    Kunz D, Bineau S, Mmaman K, Milea D, Toumi M. Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database. Expert Opin Pharmacother 2012; 13: 916.
  • 47
    Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs 2009; 23: 1934.
  • 48
    O'Brien CP. Benzodiazepine use, abuse and dependence. J Clin Psychiatry 2005; 66: (Suppl 2): 2833.